BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19461298)

  • 1. Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans.
    van Dorp EL; Kest B; Kowalczyk WJ; Morariu AM; Waxman AR; Arout CA; Dahan A; Sarton EY
    Anesthesiology; 2009 Jun; 110(6):1356-63. PubMed ID: 19461298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
    Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
    Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nociception increases during opioid infusion in opioid receptor triple knock-out mice.
    Juni A; Klein G; Pintar JE; Kest B
    Neuroscience; 2007 Jun; 147(2):439-44. PubMed ID: 17544222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment.
    Juni A; Klein G; Kowalczyk B; Ragnauth A; Kest B
    Neuropharmacology; 2008 Jun; 54(8):1264-70. PubMed ID: 18457849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.
    Ulens C; Baker L; Ratka A; Waumans D; Tytgat J
    Biochem Pharmacol; 2001 Nov; 62(9):1273-82. PubMed ID: 11705461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice.
    Campillo A; Cabañero D; Romero A; García-Nogales P; Puig MM
    Eur J Pharmacol; 2011 Apr; 657(1-3):89-96. PubMed ID: 21300053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor.
    Juni A; Cai M; Stankova M; Waxman AR; Arout C; Klein G; Dahan A; Hruby VJ; Mogil JS; Kest B
    Anesthesiology; 2010 Jan; 112(1):181-8. PubMed ID: 19996949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.
    Francés B; Gout R; Campistron G; Panconi E; Cros J
    Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
    Kalra A; Urban MO; Sluka KA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous opioid and cannabinoid systems modulate the muscle pain: A pharmacological study into the peripheral site.
    Gonçalves WA; Ferreira RCM; Rezende BM; Mahecha GAB; Gualdron M; de Macedo FHP; Duarte IDG; Perez AC; Machado FS; Cruz JS; Romero TRL
    Eur J Pharmacol; 2021 Jun; 901():174089. PubMed ID: 33826922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic effects of morphine-6beta-glucuronide.
    Lötsch J
    Anesthesiology; 2009 Jun; 110(6):1209-10. PubMed ID: 19417609
    [No Abstract]   [Full Text] [Related]  

  • 19. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone.
    Crain SM; Shen KF
    Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity.
    Yoburn BC; Shah S; Chan K; Duttaroy A; Davis T
    Pharmacol Biochem Behav; 1995; 51(2-3):535-9. PubMed ID: 7667382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.